» Articles » PMID: 18551144

Molecular Analysis of Human Cancer Cells Infected by an Oncolytic HSV-1 Reveals Multiple Upregulated Cellular Genes and a Role for SOCS1 in Virus Replication

Overview
Date 2008 Jun 14
PMID 18551144
Citations 14
Authors
Affiliations
Soon will be listed here.
Abstract

Oncolytic herpes simplex viruses (oHSVs) are promising anticancer therapeutics. We sought to characterize the functional genomic response of human cancer cells to oHSV infection using G207, an oHSV previously evaluated in a phase I trial. Five human malignant peripheral nerve sheath tumor cell lines, with differing sensitivity to oHSV, were infected with G207 for 6 h. Functional genomic analysis of virus-infected cells demonstrated large clusters of downregulated cellular mRNAs and smaller clusters of those upregulated, including 21 genes commonly upregulated in all five lines. Of these, 7 are known to be HSV-1 induced and 14 represent novel virus-regulated genes. Gene ontology analysis revealed that a majority of G207-upregulated genes are involved in Janus kinase/signal transducer and activator of transcription signaling, transcriptional regulation, nucleic acid metabolism, protein synthesis and apoptosis. Ingenuity networks highlighted nodes for AP-1 subunits and interferon signaling via STAT1, suppressor of cytokine signaling-1 (SOCS1), SOCS3 and RANTES. As biological confirmation, we found that virus-mediated upregulation of SOCS1 correlated with sensitivity to G207 and that depletion of SOCS1 impaired virus replication by >10-fold. Further characterization of roles provided by oHSV-induced cellular genes during virus replication may be utilized to predict oncolytic efficacy and to provide rational strategies for designing next-generation oncolytic viruses.

Citing Articles

A Sequencing Overview of Malignant Peripheral Nerve Sheath Tumors: Findings and Implications for Treatment.

Xiao K, Yang K, Hirbe A Cancers (Basel). 2025; 17(2).

PMID: 39857962 PMC: 11763529. DOI: 10.3390/cancers17020180.


UBR5 in Tumor Biology: Exploring Mechanisms of Immune Regulation and Possible Therapeutic Implications in MPNST.

Odhiambo D, Fan S, Hirbe A Cancers (Basel). 2025; 17(2).

PMID: 39857943 PMC: 11764400. DOI: 10.3390/cancers17020161.


Rational strategies for designing next-generation oncolytic viruses based on transcriptome analysis of tumor cells infected with oncolytic herpes simplex virus-1.

Javid N, Abdoli S, Shahbazi M Front Oncol. 2025; 14():1469511.

PMID: 39850819 PMC: 11754274. DOI: 10.3389/fonc.2024.1469511.


Targeting High-Risk Neuroblastoma Patient-Derived Xenografts with Oncolytic Virotherapy.

Quinn C, Beierle A, Hutchins S, Marayati R, Bownes L, Stewart J Cancers (Basel). 2022; 14(3).

PMID: 35159029 PMC: 8834037. DOI: 10.3390/cancers14030762.


SOCS Proteins Participate in the Regulation of Innate Immune Response Caused by Viruses.

Huang S, Liu K, Cheng A, Wang M, Cui M, Huang J Front Immunol. 2020; 11:558341.

PMID: 33072096 PMC: 7544739. DOI: 10.3389/fimmu.2020.558341.


References
1.
Hill J, Lukiw W, Gebhardt B, Higaki S, Loutsch J, Myles M . Gene expression analyzed by microarrays in HSV-1 latent mouse trigeminal ganglion following heat stress. Virus Genes. 2002; 23(3):273-80. DOI: 10.1023/a:1012517221937. View

2.
Rottapel R, Ilangumaran S, Neale C, La Rose J, Barber D, Dubreuil P . The tumor suppressor activity of SOCS-1. Oncogene. 2002; 21(28):4351-62. DOI: 10.1038/sj.onc.1205537. View

3.
Bedadala G, Pinnoji R, Hsia S . Early growth response gene 1 (Egr-1) regulates HSV-1 ICP4 and ICP22 gene expression. Cell Res. 2007; 17(6):546-55. PMC: 7092374. DOI: 10.1038/cr.2007.44. View

4.
Mineta T, Rabkin S, Yazaki T, Hunter W, Martuza R . Attenuated multi-mutated herpes simplex virus-1 for the treatment of malignant gliomas. Nat Med. 1995; 1(9):938-43. DOI: 10.1038/nm0995-938. View

5.
Bell J . Oncolytic viruses: what's next?. Curr Cancer Drug Targets. 2007; 7(2):127-31. DOI: 10.2174/156800907780058844. View